Phio Pharmaceuticals Corp (PHIO)
0.6919
0.00 (0.00%)
USD |
NASDAQ |
Jun 28, 16:00
0.6919
0.00 (0.00%)
After-Hours: 20:00
Phio Pharmaceuticals Cash from Financing (Quarterly): -0.004M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.004M |
| December 31, 2023 | 2.403M |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 5.048M |
| March 31, 2023 | -0.038M |
| December 31, 2022 | 0.002M |
| September 30, 2022 | -0.003M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -0.025M |
| December 31, 2021 | -0.001M |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 21.72M |
| December 31, 2020 | 0.00 |
| September 30, 2020 | -0.017M |
| June 30, 2020 | 7.612M |
| March 31, 2020 | 8.536M |
| December 31, 2019 | 0.766M |
| September 30, 2019 | -0.055M |
| June 30, 2019 | 0.018M |
| March 31, 2019 | 0.043M |
| December 31, 2018 | 13.39M |
| September 30, 2018 | -0.068M |
| June 30, 2018 | 4.569M |
| March 31, 2018 | 0.932M |
| Date | Value |
|---|---|
| December 31, 2017 | 0.366M |
| September 30, 2017 | -0.074M |
| June 30, 2017 | 0.00 |
| March 31, 2017 | 0.00 |
| December 31, 2016 | 10.05M |
| September 30, 2016 | 0.152M |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 0.182M |
| September 30, 2015 | 0.012M |
| June 30, 2015 | 9.237M |
| March 31, 2015 | 0.064M |
| December 31, 2014 | -0.03M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 1.977M |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.028M |
| September 30, 2013 | -0.007M |
| June 30, 2013 | 0.002M |
| March 31, 2013 | 15.64M |
| December 31, 2012 | -0.003M |
| September 30, 2012 | -0.007M |
| June 30, 2012 | 8.67M |
| March 31, 2012 | 1.01M |
| December 31, 2011 | 2.95M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.055M
Minimum
Sep 2019
21.72M
Maximum
Mar 2021
2.298M
Average
--
Median
Dec 2020
Cash from Financing (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.597M |
| Palatin Technologies Inc | 9.136M |
| iBio Inc | 5.025M |
| Theriva Biologics Inc | 0.00 |
| Oragenics Inc | 1.653M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.011M |
| Free Cash Flow | -10.05M |
| Free Cash Flow Per Share (Quarterly) | -0.4391 |
| Free Cash Flow Yield | -494.2% |